Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed-Reference-Cited by-同舟云学术

Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed

Published:2011-12 Issue: Volume:22 Page:viii45-viii48
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Rustin G.J.S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/Suppl_8/viii45/601607/mdr471.pdf

Reference11 articles.

1. What do patients think about CA-125 monitoring in the follow-up? Results form a multi-center trial in 1060 patients with ovarian cancer;Oskay-Oezcelik;J Clin Oncol,2009

2. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial;Rustin;Lancet,2010

3. Potential survival benefit of secondary cytoreductive surgery for recurrent epithelial ovarian, tubal, and peritoneal cancers;Goto;Int J Gynecol Cancer,2011

4. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial;Harter;Ann Surg Oncol,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer;Cancer Research;2023-12-01

2. Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment;Cochrane Database of Systematic Reviews;2023-08-31

3. CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data;Cancers;2023-03-17

4. Imaging Recommendations for Diagnosis, Staging, and Management of Ovarian and Fallopian Tube Cancers;Indian Journal of Medical and Paediatric Oncology;2023-01-24

5. Epithelial ovarian cancer;DiSaia and Creasman Clinical Gynecologic Oncology;2023